Latest Threads on News from companies

Abu Dhabi Stem Cells Center (ADSCC) and Burjeel Holdings PLC have formed a strategic partnership to expand bone marrow transplant and cellular therapy services at Burjeel Medical City (BMC). This collaboration aims to enhance access to advanced care for patients with blood cancer, genetic diseases, autoimmune diseases, and other conditions, establishing Abu Dhabi as a global healthcare destination. ADSCC will extend its proprietary Abu Dhabi Bone Marrow Transplant Program (AD-BMT©) to BMC, which is accredited by the Department of Health - Abu Dhabi and recognized by the Foundation for the Accreditation of Cellular Therapy (FACT). ADSCC has achieved significant milestones in bone marrow transplantation and CAR-T Cell Therapy since 2020. The Burjeel Cancer Institute (BCI) at BMC has also pioneered bone marrow transplants, including the UAE’s first pediatric BMT in 2022. The partnership aims to create an integrated ecosystem for advanced research, cellular therapy, and regenerative medicine, benefiting new and existing patients. Both institutions are committed to setting new benchmarks in patient outcomes and medical excellence.

Sean Magee, Board Secretary, addressed a letter dated 18 September 2024 to H.E Dr. Maryam Buti Al Suwaidi, CEO of the Securities & Commodities Authority, and H.E Hamed Ali, CEO of the Dubai Financial Market. The letter clarifies recent media reports about statements attributed to Tabreed's CEO regarding future expansion into new markets. The company states that these quotes were inaccurate and that the CEO was speaking hypothetically about growth aspirations rather than concrete plans. Tabreed is focused on exploring promising investment opportunities to create long-term value for shareholders and operates in the UAE, four GCC countries, India, and Egypt. The company reaffirms its commitment to transparency and disclosure requirements and will disclose material information to the market once finalized. For further information, recipients are invited to contact the company.

On September 18, 2024, Amlak Finance PJSC announced the sale of an investment unit in Dubai to an Amlak employee. The transaction, representing 0.04% of the company's capital, involves a down payment and a three-year installment plan. There are no deviations from approved policies, and the sale complies with UAE Central Bank regulation No 112-2018, which requires the disposal of foreclosed units within three years of acquisition. The unit's evaluation was conducted by "British Arabian" and "Colliers." Amlak Finance PJSC confirms that the deal's terms are fair, reasonable, and in the interest of the company's shareholders. The announcement was authorized by Lama Takieddin, Head of Corporate Governance and Company Secretary.

On 18 September 2024, Amlak Finance P.J.S.C held a board meeting from 3:00 PM to 4:15 PM. All seven board members were present, achieving a 100% quorum. The board discussed routine business matters. The meeting's authorized signatory was Lama Takieddin, Head of Corporate Governance and Company Secretary.

Date: 18 September 2024 Ref: LM_LTR_030_2024 To: Mr. Hamed Ahmed Ali, CEO, Dubai Financial Market, Dubai, UAE Subject: Dubai Refreshment P.J.S.C Board of Directors to Issue Resolution by Circulation The Board of Directors of Dubai Refreshment P.J.S.C will issue a resolution by circulation on Monday, 23rd September 2024, regarding the dividends distribution approved by the Company's General Assembly on 27th March 2024. With Kind Regards, Karem Mahmoud Director of Legal Dubai Refreshment P.J.S.C

Date: 18 September 2024 Ref: LM_LTR_030_2024 To: Hamed Ahmed Ali, CEO, Dubai Financial Market, Dubai, UAE Subject: Dubai Refreshment P.J.S.C Board of Directors to Issue Resolution by Circulation The Board of Directors of Dubai Refreshment P.J.S.C will issue a resolution by circulation on Monday, 23rd September 2024, regarding the dividends distribution approved by the Company’s General Assembly on 27th March 2024. Regards, Karem Mahmoud Director of Legal Dubai Refreshment P.J.S.C